Nuclear Medicine Equipment Market Size, Share, Opportunities,

Nuclear Medicine Equipment Market Report

According to IMARC Group’s latest report, titled “Nuclear Medicine Equipment Market: Global Industry Trends, Share, Size, Growth, Opportunities, and Forecast 2022-2027”, the global nuclear medicine equipment market size has reached $2.7 billion in 2021. Going forward, IMARC Group expects the market to reach US$4 billion by 2027 growing at a CAGR of 6.8% in the period 2022 -2027.

Report metric
History: 2016-2021
Base year: 2021
Forecast year: 2022-2027

Download a free sample of the report: https://www.imarcgroup.com/nuclear-medicine-equipment-market/requestsample

Nuclear Medicine Equipment Market Industry Definition and Application:

Nuclear medicine equipment refers to medical devices that use radioactive materials or radionuclides to generate anatomical images and record disease progression. Radionuclides represent the cleaning molecules composed with excessive energy used for the manufacture of radiopharmaceuticals. Nuclear medicine equipment is used to examine various biological processes, such as tissue blood flow, cell receptor functioning, metabolism, neurotransmitter activity, and apoptosis. Additionally, they use Single Photon Emission Computed Tomography (SPECT) imaging technologies and specialized gamma cameras to detect movement disorders and several types of dementia. As a result, nuclear medicine equipment finds wide application in the treatment of gastrointestinal, endocrine, oncological, cardiovascular and neurological disorders throughout the world.

As the novel coronavirus (COVID-19) crisis engulfs the world, we continuously monitor changes in markets, as well as industry consumer behaviors around the world and our estimates on the latest market trends and forecasts are made. after considering the impact of this pandemic.

Nuclear Medicine Equipment Market Trends and Drivers:

Rising prevalence of chronic medical conditions and increasing geriatric population that is more prone to age-related and associated diseases are some of the major factors driving the nuclear medicine equipment market. Furthermore, the growing requirement for personalized drugs among patients and healthcare professionals further increases the market growth. Additionally, various technological advancements, including the development of data-integrated imaging systems and radiotracers that allow computer-assisted image reconstruction and processing and accurate recognition of medical conditions to compare diagnostic scans and monitor the progression of a disease, also catalyze the global market. Apart from this, healthcare institutions are moving from stand-alone imaging techniques to hybrid imaging techniques to generate accurate and high-resolution images, which act as important growth factors. In addition, the extensive research and development (R&D) activities in the field of biotechnology and increasing improvements in medical infrastructure, especially in developing economies, are expected to propel the nuclear medicine equipment market during the forecast period.

Browse the full report with TOC: https://www.imarcgroup.com/nuclear-medicine-equipment-market

Nuclear Medicine Equipment Market Segmentation:

Competitive Landscape:

The report has segmented the market based on region, product, application, and end user.

Breakdown by product:

Single photon emission tomography
Autonomous
Hybrid
Positron emission tomography
Autonomous
Hybrid
Planar scintigraphy

Breakdown by application:

Neurology
Oncology
Cardiology
Others

Breakdown by end user:

Hospitals
Imaging centers
Academic and research institutes
Others

Breakdown by region:

North America (USA, Canada)
Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, others)
Middle East and Africa

Who are the key players in the Nuclear Medicine Equipment Market?

The report provides a detailed analysis of market leaders including.

Biodex Medical Systems Inc. (Mirion Technologies Inc.), Cardinal Health Inc., CMR Naviscan Corporation, DDD-Diagnostic A/S, Digirad Corporation, General Electric Company, Koninklijke Philips NV, Mediso Ltd., Neusoft Corporation, Siemens AG, SurgicEye GmbH and Toshiba Corporation.

Related report from the IMARC group:

Behavioral Rehabilitation Market Report: https://www.imarcgroup.com/behavioral-rehabilitation-market

Onychomycosis Treatment Market Report: https://www.imarcgroup.com/onychomycosis-treatment-market

Lateral Flow Testing Market Report: https://www.imarcgroup.com/lateral-flow-assay-market

Formulation Development Outsourcing Market Report: https://www.imarcgroup.com/formulation-development-outsourcing-market

Drug Device Combination Products Market Report: https://www.imarcgroup.com/drug-device-combination-products-market

Nanopore Technology Market Report: https://www.imarcgroup.com/nanopore-technologies-market

Europe DNA Sequencing Products Market Report: https://www.imarcgroup.com/europe-dna-sequencing-products-market

Pyrogen Testing Market Report: https://www.imarcgroup.com/pyrogen-testing-market

IMARC Group
30 N Gould St Ste R
Sheridan, Wyoming 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Such. :(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.

IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.

This press release was published on openPR.

Comments are closed.